How did the Polynovo (ASX:PNV) share price respond last earnings season?

The medical device company delivers its full 2021 financial year results tomorrow.

| More on:
A doctor looks unsure, indicating share price uncertainty for ASX medical companies

Image source: Getty images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price is up 1.9% in late afternoon trading to $2.13 per share.

The S&P/ASX 200 Index (ASX: XJO), meanwhile, is struggling to hold on to its earlier gains, though currently still up 0.2%.

Polynovo is under the microscope today as the ASX medical device developer gets set to deliver its full year 2021 financial results (FY21) tomorrow.

With investors keenly awaiting Thursday's results, we look back to how the Polynovo share price moved following the release of its FY20 results.

What did Polynovo report in FY20?

The Polynovo share price fell 6.5% on 26 August 2020, the day the company reported its FY20 results.

The fall came despite a 104% increase in sales revenue reported over the year, to $19.1 million. Revenue grew across the company's markets, with particularly strong growth in the United States.

Likely contributing to Polynovo shares falling after last year's results was the 28.8% year-on-year increase in operating expenses which reached $22.6 million. The company reported an operating loss of $1.1 million and a net loss after tax of $4.2 million.

Polynovo finished off FY20 with a cash balance of $11.6 million.

No guidance was offered for FY21. However, management said at the time they planned to reinvest funds back into the business for new product development and to expand into new markets.

Polynovo share price snapshot

Over the past 12 months, Polynovo's share price is down 10%. By comparison the ASX 200 is up 22% since this time last year.

Year-to-date, the Polynovo has yet to recover from the sharp falls it suffered in January. Its shares are down 45% in 2021.

Should you invest $1,000 in Polynovo Limited right now?

Before you buy Polynovo Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Polynovo Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 9 January 2025

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Three happy girls on jumping motion with inflatable mattresses at the beach.
Share Gainers

3 ASX All Ords shares leading the charge in 2025

These ASX All Ords shares have soared 16% to 37% already in 2025.

Read more »

Happy healthcare workers in a labs
Healthcare Shares

3 ASX 200 healthcare stocks with 'strong return potential' in 2025

A leading investment manager expects 2025 will be a good year for these ASX 200 healthcare companies.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Why are Mesoblast shares in a trading halt?

The biotech company requested a trading halt before the market open on Friday. Here's why.

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

ASX All Ords stock rockets 18% on FDA clearance

This stock is making very healthy returns on US news.

Read more »

rising medical asx share price represented by excited doctors dancing in ward
Healthcare Shares

Up 77% in a month! What's going on with the Mesoblast share price?

This stock has blown the lights out in recent weeks...

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

Guess which ASX healthcare stock is up 31% on big news

What is getting investors excited on Tuesday? Let's find out.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

Healthy gains: 5 best ASX 200 healthcare shares of 2024

Four of the five best-performing ASX 200 healthcare stocks of 2024 more than doubled in value.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Why did the CSL share price go backwards in 2024?

CSL shares closed out 2024 in the red. But why?

Read more »